Xylem Inc.: valuation
What the market value assumes, and what the company's own statements and its peers' prices would put it at. Every assumption is yours to change.
Cash-flow value and what the price assumes
Average of FY2023–FY2025 (cash from operations less capital spending), from the statements below.
Starts at revenue growth over the last three years, 17.8% a year (statements).
US Treasury 10-year yield on Nov 13, 2026: 5.15% (US Treasury).
Your assumption: the extra yearly return you want for holding shares rather than Treasuries. 5% is a round starting figure, not data.
Your assumption: long-run growth, usually near inflation. It must stay below the discount rate.
Debt less cash at the end of FY2025 (statements); negative means more cash than debt.
What today's price assumes
A market value of $20.2 B means free cash flow growing 11.4% a year for 10 years, then 2.5% for ever, at a 10.15% discount rate.
Revenue grew 17.8% a year over the last three years.
Against the market value, for other rates
Cash-flow value of the shares as a percentage above or below today's market value; your inputs in the middle.
| Discount rate ↓ / growth → | 12.84% | 15.34% | 17.84% | 20.34% | 22.84% |
|---|---|---|---|---|---|
| 8.15% | +59% | +93% | +134% | +183% | +242% |
| 9.15% | +31% | +59% | +92% | +131% | +179% |
| 10.15% | +11% | +34% | +61% | +94% | +133% |
| 11.15% | -4% | +15% | +38% | +65% | +98% |
| 12.15% | -16% | +0% | +20% | +43% | +71% |
On one scale
Bars: from the 25th to the 75th percentile multiple of the peers, the line at the median; dot: the cash-flow value with your inputs.
Your own DCF model
A full discounted-cash-flow model of Xylem Inc., started from its filings: revenue growth and margins year by year, bear, base and bull cases, the WACC and its parts, sensitivity tables and a value per share against the dated market price. Save it, share it with your team or by a read-only link.
Open the DCF modelAgainst the industry Industrial Machinery
Multiples of its companies with a market value at most 60 days old, times Xylem Inc.'s own figures of FY2025.
| Multiple | Peers (25th / median / 75th) | Xylem Inc. | Applied to | Value (25th to 75th) | Companies |
|---|---|---|---|---|---|
| P/E | 22.3× / 32.8× / 49.3× | 18.7× | net income $957 M | $21.3 B to $47.2 B | 82 |
| Price to sales | 2.1× / 3.4× / 5.3× | 2.2× | revenue $9.0 B | $18.9 B to $47.4 B | 87 |
| Price to book | 3.0× / 4.8× / 8.0× | 1.8× | book equity $11.5 B | $33.9 B to $91.4 B | 82 |
Peers' multiples from the distributions by industry; the company's figures from its statements below. A multiple says what similar companies cost, not what this one is worth.
Against its own history
Xylem Inc.'s multiples at each month end with a market cap on file, Jan 2020 to Oct 2026, each against its own median.
P/E
19.9×Now below its median of 34.6×, in the bottom quarter of its range; range 19.9× to 82.0× over 29 months.
Price to sales
2.2×Now below its median of 3.5×, in the bottom quarter of its range; range 2.2× to 4.9× over 29 months.
Price to book
1.8×Now below its median of 2.9×, in the bottom quarter of its range; range 1.8× to 7.8× over 29 months.
as of Oct 29, 2026. Market caps: the dated values on file since 2020, and in between the SEC's fails-to-deliver closing price times the share count on the latest 10-K or 10-Q cover. Each month divides by the last twelve months' results that had been published by then (a quarter 45 days after it ended, a fiscal year 60 days after), so the past is not read with figures that came out later; months with a loss give no P/E. Newest month: Oct 29, 2026.
The statements it starts from
USD millions at each year's exchange rate; free cash flow = cash from operations less capital spending.
| Fiscal year | Revenue | Net income | Cash from operations | Capital spending | Free cash flow | Net debt | Source |
|---|---|---|---|---|---|---|---|
| FY2025to Dec 31, 2025 | $9.0 B | $957 M | $1.2 B | $331 M | $910 M | $475 M | SEC annual report (10-K, 20-F) |
| FY2024to Dec 31, 2024 | $8.6 B | $890 M | $1.3 B | $321 M | $942 M | $910 M | SEC annual report (10-K, 20-F) |
| FY2023to Dec 31, 2023 | $7.4 B | $609 M | $837 M | $271 M | $566 M | $1.2 B | SEC annual report (10-K, 20-F) |
| FY2022to Dec 31, 2022 | $5.5 B | $355 M | $596 M | $208 M | $388 M | $936 M | SEC annual report (10-K, 20-F) |
| FY2021to Dec 31, 2021 | $5.2 B | $427 M | $538 M | $208 M | $330 M | $1.1 B | SEC annual report (10-K, 20-F) |
| FY2020to Dec 31, 2020 | $4.9 B | $254 M | $824 M | $183 M | $641 M | $609 M | SEC annual report (10-K, 20-F) |
Each figure as filed; the full statements with every line and its filing are on the company page. Market value $20.2 B on Oct 29, 2026.
How it is worked out: the cash-flow value is free cash flow grown at the first-stage rate for the years chosen, then at the long-run rate for ever, each year discounted at the risk-free rate plus the equity risk premium, less net debt. What the price assumes is the first-stage growth that makes that value equal today's market value. The starting cash flow, growth and net debt come from the statements; the risk-free rate from the US Treasury; the premium and the long-run growth are assumptions and are labelled so. This is arithmetic on reported figures, not advice.